Diagnosis: Pheochromocytoma -- a catecholamine secreting ... taken three times per day), but did not have a history of hypertension or any other notable conditions. On arrival she was asymptomatic.

She had had hypertension for 10 years and had taken ... This response is very similar to that described in the patient with pheochromocytoma of Koffler and others, 10 referred to above.

The clinical presentation of pheochromocytoma is highly variable, making this condition a diagnostic challenge. The signs and symptoms include paroxysmal hypertension, headaches, episodic pallor ...

7 The hypertension and tachycardia caused by ... The use of dibenamine in the diagnosis of a case of pheochromocytoma has recently been described. 9 An adrenolytic drug, 933 F (2-piperidino ...

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and ...

Only 9 of the 17 patients in this cohort had hypertension, and 3 had cardiovascular crises in the context of elective surgeries. This justifies ruling out pheochromocytoma in NF1 patients before ...

renovascular hypertension, pheochromocytoma and familial hyperkalemic hypertension. Working with mentor Richard Gordon, he helped to demonstrate that primary aldosteronism is at least 10 times ...

b Performed 3 months later at the outpatient clinic. c For conversion to mg/dl divide by 0.0555. d For conversion to mg/dl divide by 88.4. a Performed at presentation. b Performed 3 months later ...